ACLARIS THERAPEUTICS INC (ACRS) Institutional Shareholders
ACLARIS THERAPEUTICS INC (ACRS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $454.31M in ACRS holdings during the latest filing period.
Bml Capital Management, Llc is currently the largest disclosed institutional shareholder of ACRS tracked by InsiderSet, reporting ownership valued at approximately $63.35M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $70.77M, representing an estimated gain of +11.72% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 64% of the total disclosed ACRS value among the investors covered in this analysis. Major shareholders include Bml Capital Management, Llc, Blackrock, Inc., Deep Track Capital, Lp, and several other long-term asset managers with concentrated positions in ACLARIS THERAPEUTICS INC (ACRS).
This page ranks the largest institutional ACRS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
141
Total Reported Value
$454.31M
Largest Holder
Bml Capital Management, Llc
Largest Position
$63.35M
Insider Transactions (90d)
8
Latest Filing Quarter
Q2 2026
New Institutional Positions
162
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Bml Capital Management, Llc | 36.18% | 11,975,000 | $63,347,750 | $70,772,250 | +$7,424,500 | +11.72% | |
| Blackrock, Inc. | 0.00% | 10,037,008 | $53,095,772 | $59,318,717 | +$6,222,945 | +11.72% | |
| Deep Track Capital, Lp | 0.72% | 9,345,000 | $35,043,750 | $55,228,950 | +$20,185,200 | +57.60% | |
| Ra Capital Management, L.P. | 0.27% | 6,804,072 | $25,515,270 | $40,212,066 | +$14,696,796 | +57.60% | |
| Vivo Capital, Llc | 2.09% | 6,666,666 | $24,999,998 | $39,399,996 | +$14,399,998 | +57.60% | |
| Vanguard Capital Management Llc | 0.00% | 5,167,469 | $19,378,009 | $30,539,742 | +$11,161,733 | +57.60% | |
| Frazier Life Sciences Management, L.P. | 0.48% | 4,925,374 | $18,470,153 | $29,108,960 | +$10,638,807 | +57.60% | |
| State Street Corp | 0.00% | 3,255,340 | $17,220,749 | $19,239,059 | +$2,018,310 | +11.72% | |
| Rock Springs Capital Management Lp | 0.99% | 4,472,650 | $16,772,438 | $26,433,362 | +$9,660,924 | +57.60% | |
| Decheng Capital Llc | 2.29% | 4,041,736 | $15,156,510 | $23,886,660 | +$8,730,150 | +57.60% | |
| Adage Capital Partners Gp, L.L.C. | 0.02% | 3,871,000 | $14,516,250 | $22,877,610 | +$8,361,360 | +57.60% | |
| Balyasny Asset Management L.P. | 0.02% | 3,361,328 | $12,604,980 | $19,865,448 | +$7,260,468 | +57.60% | |
| Morgan Stanley | 0.00% | 2,746,302 | $10,298,633 | $16,230,645 | +$5,932,012 | +57.60% | |
| Geode Capital Management, Llc | 0.00% | 2,423,691 | $9,091,533 | $14,324,014 | +$5,232,481 | +57.55% | |
| Citadel Advisors Llc | 0.01% | 2,249,319 | $8,434,946 | $13,293,475 | +$4,858,529 | +57.60% | |
| Panagora Asset Management Inc | 0.02% | 1,356,152 | $7,174,044 | $8,014,858 | +$840,814 | +11.72% | |
| Braidwell Lp | 0.21% | 1,699,116 | $6,371,685 | $10,041,776 | +$3,670,091 | +57.60% | |
| Vanguard Portfolio Management Llc | 0.00% | 1,656,066 | $6,210,248 | $9,787,350 | +$3,577,102 | +57.60% | |
| Palo Alto Investors Lp | 0.93% | 1,613,430 | $6,050,363 | $9,535,371 | +$3,485,008 | +57.60% | |
| Woodline Partners Lp | 0.02% | 1,485,623 | $5,571,086 | $8,780,032 | +$3,208,946 | +57.60% | |
| Deutsche Bank Ag\ | 0.00% | 1,040,955 | $5,506,652 | $6,152,044 | +$645,392 | +11.72% | |
| Connor, Clark & Lunn Investment Management Ltd. | 0.01% | 1,418,360 | $5,318,850 | $8,382,508 | +$3,063,658 | +57.60% | |
| Kalehua Capital Management Llc | 4.23% | 1,337,556 | $5,015,835 | $7,904,956 | +$2,889,121 | +57.60% | |
| Three Bridge Wealth Advisors, Llc | 0.95% | 714,823 | $3,781,414 | $4,224,604 | +$443,190 | +11.72% | |
| Aldebaran Capital, Llc | 2.72% | 947,162 | $3,551,858 | $5,597,727 | +$2,045,869 | +57.60% | |
| D. E. Shaw & Co., Inc. | 0.00% | 900,804 | $3,378,015 | $5,323,752 | +$1,945,737 | +57.60% | |
| Millennium Management Llc | 0.00% | 756,127 | $2,835,476 | $4,468,711 | +$1,633,235 | +57.60% | |
| Northern Trust Corp | 0.00% | 728,225 | $2,730,844 | $4,303,810 | +$1,572,966 | +57.60% | |
| Marshall Wace, Llp | 0.00% | 712,984 | $2,673,691 | $4,213,735 | +$1,540,044 | +57.60% | |
| Vanguard Fiduciary Trust Co | 0.00% | 628,859 | $2,358,221 | $3,716,557 | +$1,358,336 | +57.60% | |
| Goldman Sachs Group Inc | 0.00% | 588,691 | $2,207,592 | $3,479,164 | +$1,271,572 | +57.60% | |
| Russell Investments Group, Ltd. | 0.00% | 365,055 | $1,931,139 | $2,157,475 | +$226,336 | +11.72% | |
| Dimensional Fund Advisors Lp | 0.00% | 511,461 | $1,914,370 | $3,022,735 | +$1,108,365 | +57.90% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 502,631 | $1,884,866 | $2,970,549 | +$1,085,683 | +57.60% |
| Logos Global Management Lp | 0.10% | 500,000 | $1,875,000 | $2,955,000 | +$1,080,000 | +57.60% | |
| Monashee Investment Management Llc | 1.02% | 500,000 | $1,875,000 | $2,955,000 | +$1,080,000 | +57.60% | |
| Aisling Capital Management Lp | 0.34% | 434,455 | $1,629,206 | $2,567,629 | +$938,423 | +57.60% | |
| Bank Of New York Mellon Corp | 0.00% | 282,599 | $1,494,949 | $1,670,160 | +$175,211 | +11.72% | |
| Two Sigma Investments, Lp | 0.00% | 395,637 | $1,483,639 | $2,338,215 | +$854,576 | +57.60% | |
| Mpm Bioimpact Llc | 0.11% | 391,918 | $1,469,693 | $2,316,235 | +$846,542 | +57.60% | |
| Susquehanna International Group, Llp | 0.00% | 379,930 | $1,424,738 | $2,245,386 | +$820,648 | +57.60% | |
| Superstring Capital Management Lp | 0.98% | 366,490 | $1,374,338 | $2,165,956 | +$791,618 | +57.60% | |
| Bridgeway Capital Management, Llc | 0.02% | 330,019 | $1,237,571 | $1,950,412 | +$712,841 | +57.60% | |
| Hightower Advisors, Llc | 0.00% | 217,524 | $1,150,702 | $1,285,567 | +$134,865 | +11.72% | |
| Raymond James Financial Inc | 0.00% | 266,448 | $999,181 | $1,574,708 | +$575,527 | +57.60% | |
| Charles Schwab Investment Management Inc | 0.00% | 260,990 | $978,713 | $1,542,451 | +$563,738 | +57.60% | |
| Wellington Management Group Llp | 0.00% | 257,156 | $964,335 | $1,519,792 | +$555,457 | +57.60% | |
| Assenagon Asset Management S.A. | 0.00% | 154,554 | $817,591 | $913,414 | +$95,823 | +11.72% | |
| Sei Investments Co | 0.00% | 217,154 | $814,328 | $1,283,380 | +$469,052 | +57.60% | |
| Invesco Ltd. | 0.00% | 214,935 | $806,007 | $1,270,266 | +$464,259 | +57.60% |
Frequently asked questions about ACRS
Who owns the most ACRS stock?
The largest holders of ACRS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ACLARIS THERAPEUTICS INC (ACRS).
Is ACRS widely held by superinvestors?
Many widely followed stocks like ACRS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ACRS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.